Point72 Asset Management, L.P.
Position in MRVI — Maravai Lifesciences Holdings, Inc.
CIK 1603466
STAMFORD, CT
Position in MRVI
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,071,553
-$183,793 QoQ
Shares Held
3,205,496
+12.6% QoQ
Ownership
1.24%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
13 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MRVI Over Time
Shares Held
Position Value (USD)
Derivatives in MRVI
reported options exposure · as of Mar 31, 2022CallValue
$3,527,000
CallShares
100,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026Point72 Asset Management, L.P. holds $2,393,298,297 across 187 Biotechnology names. MRVI ranks #69 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APLS |
Apellis Pharmaceuticals, Inc.
|
4,183,918 | $168,319,021 | |
| 2 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
225,510 | $118,047,719 | |
| 3 | CLDX |
Celldex Therapeutics, Inc.
|
3,229,939 | $102,453,665 | |
| 4 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
846,801 | $73,646,282 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
424,750 | $71,791,245 | |
| 6 | ABVX |
Abivax S.A.
|
637,736 | $71,011,903 | |
| 7 | LEGN |
Legend Biotech Corp
|
3,886,017 | $70,298,047 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
358,634 | $67,799,757 |
All Filings in MRVI
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,071,553 | 3,205,496 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $9,255,346 | 2,847,799 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $93,969 | 32,742 | Shares | Defined | 2025-11-14 | |
| 2024-09-30 | $8,532,284 | 1,026,749 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $25,200,056 | 3,519,561 | Shares | Defined | 2024-09-16 | |
| 2024-03-31 | $12,227,838 | 1,410,362 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $6,230,360 | 951,200 | Shares | Defined | 2024-02-14 | |
| 2023-06-30 | $5,719,179 | 460,111 | Shares | Defined | 2023-08-14 | |
| 2022-09-30 | $3,855,030 | 151,000 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $3,527,000 | 100,000 | Call | Defined | 2022-05-16 | |
| 2021-12-31 | $16,378,710 | 390,900 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,355,271 | 129,488 | Shares | Defined | 2021-11-15 | |
| 2020-12-31 | $13,853,418 | 493,883 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||